Winchester, MA, United States of America

Michael John Boyd

USPTO Granted Patents = 25 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 7)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 79(Granted Patents)

Location History:

Clearwater, FL (US) (2015)
Danville, CA (US) (2018)
Winchester, MA (US) (2015 - 2019)
Soquel, CA (US) (2018 - 2022)
Arlington, TX (US) (2022)
Boston, MA (US) (2020 - 2023)
Sharon, MA (US) (2018 - 2024)

Company Filing History:

16 out of 1,149

Vertex Pharmaceuticals, Inc.

Merck Sharp + Dohme Corp.

patents

5. 6 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12384790 - Pteridinone compounds and uses thereof (2025-08-12),

2. 12331057 - Modulators of alpha-1 antitrypsin (2025-06-17),

3. 12195453 - Antiproliferation compounds and uses thereof (2025-01-14),

4. 11884672 - Modulators of alpha-1 antitrypsin (2024-01-30),

5. 11623924 - Modulators of alpha-1 antitrypsin (2023-04-11),

6. 11572364 - Pteridinone compounds and uses thereof (2023-02-07),

7. 11496033 - Device and method to generate and apply gravito-magnetic energy (2022-11-08),

8. 11440907 - Antiproliferation compounds and uses thereof (2022-09-13),

9. 11262064 - Wrist light system and method of use (2022-03-01),

10. 11059826 - Pteridinone compounds and uses thereof (2021-07-13),

11. 10875855 - Inhibitors of influenza viruses replication (2020-12-29),

12. 10815225 - Antiproliferation compounds and uses thereof (2020-10-27),

13. 10533004 - Methods of preparing inhibitors of influenza viruses replication (2020-01-14),

14. 10301304 - Selective inhibitor of phosphatidylinositol 3-kinase-gamma (2019-05-28),

15. 10273233 - Inhibitors of influenza viruses replication (2019-04-30),

Title: Unveiling the Innovative Journey of Inventor Michael John Boyd

Introduction:

Innovation knows no bounds, and Inventor Michael John Boyd is a living testament to this fact. Hailing from Winchester, MA (US), he has made significant strides in the field of science and medicine, with an impressive portfolio of 15 patents under his name.

Latest Patents:

Among his latest patents are groundbreaking inventions that include "Modulators of alpha-1 antitrypsin" and "Pteridinone compounds and uses thereof." These inventive compounds, compositions, and methods have the potential to revolutionize the treatment of conditions such as alpha-1 antitrypsin deficiency (AATD) and cellular proliferative disorders like cancer.

Career Highlights:

Michael John Boyd has lent his expertise to renowned companies such as Vertex Pharmaceuticals, Inc. and Merck Canada Inc., where his innovative spirit thrived. His contributions have not only enhanced his own portfolio but have also left a lasting impact on the scientific community.

Collaborations:

Collaboration is key to success in the world of innovation, and Michael John Boyd has had the privilege of working alongside talented individuals like Hongbo Deng and Tiansheng Wang. Their collective efforts have led to the creation of groundbreaking solutions that have the potential to change lives.

Conclusion:

In conclusion, Michael John Boyd's journey as an inventor is a testament to his dedication, ingenuity, and passion for creating solutions that make a difference. With an impressive array of patents to his name and a legacy of collaboration and innovation, he continues to inspire generations to push the boundaries of what is possible in the realm of science and medicine.

This text is generated by artificial intelligence and may not be accurate.